Overexpression of the thymidine kinase 1 (TK1) and the cyclin-dependent kinase 9 (CDK9) in plasma-derived exosomes was significantly correlated with clinical resistance to CDK4/6 inhibitors in metastatic breast cancer patients [28]. Here, TK1 is linked to breast carcinoma.